Global Expansion The company's recent expansion into the United States and other international markets presents a significant opportunity to offer complementary laboratory automation solutions, reagents, and support services to newly established and expanding laboratories.

Infectious Disease Focus With a strong emphasis on infectious diseases such as multiple myeloma and autoimmune conditions, there is potential to promote advanced diagnostic reagents, testing kits, and automation systems to healthcare providers and labs involved in infectious disease testing.

Technological Integration The company's use of sophisticated tech stacks like Microsoft Dynamics 365 and Office 365 indicates an openness to digital solutions, which can be leveraged to introduce integrated laboratory management and data analytics tools that enhance test automation and traceability.

Emerging Market Interest Awards and collaborations in rapidly growing markets like India suggest a promising sales window for expanding diagnostics portfolios, including immunoassays and automated testing platforms tailored to emerging healthcare infrastructure needs.

Innovative Test Development The company's ongoing development of advanced diagnostic tests such as the minimal residual disease and multiple myeloma assays offers an entry point to position laboratory automation systems, sample processing equipment, and reagent kits aligned with cutting-edge diagnostics solutions.